Literature DB >> 17936248

Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.

No Soo Kim1, Kyungwon Kang, Min Ho Cha, Bong-Joo Kang, Jinseok Moon, Byoung Kab Kang, Byeong-Chan Yu, Yoon-Sik Kim, Sun Mi Choi, Ok-Sun Bang.   

Abstract

Paraoxonase-1 (PON1) is an enzyme associated with HDL in blood and it is considered as an anti-oxidant factor due to its capability to prevent lipid oxidation. In vivo mouse studies also have shown that PON1 is one of the genetic risk factors contributing to atherosclerosis. In this study, we evaluated the serum PON1 activities of sex-age matched Korean healthy control and ischemic stroke patients, and investigated the association of PON1 activity with other metabolic parameters. Statistical analyses revealed that PON1 activity and HDL_cholesterol (HDL_C) in stroke patients were significantly decreased when compared with those of healthy control. Additionally, PON1 activity was negatively correlated with age, whereas it was positively correlated with HDL_C in a stroke group. Overall, the results of this study indicated that decreased serum PON1 activity should be considered as a risk factor for ischemic stroke in Koreans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936248     DOI: 10.1016/j.bbrc.2007.09.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats.

Authors:  Aysel Kiyici; Nilsel Okudan; Hakki Gökbel; Muaz Belviranli
Journal:  J Med Food       Date:  2010-06       Impact factor: 2.786

Review 2.  Genetics of stroke.

Authors:  Jin-min Guo; Ai-jun Liu; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

3.  R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Authors:  Abdolkarim Mahrooz; Ghorban Gohari; Mohammad-Bagher Hashemi; Mehryar Zargari; Hadis Musavi; Mahmoud Abedini; Ahad Alizadeh
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 4.  Genetic susceptibility to cerebrovascular disease.

Authors:  David Della-Morte; Francesca Pacifici; Tatjana Rundek
Journal:  Curr Opin Lipidol       Date:  2016-04       Impact factor: 4.776

5.  Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.

Authors:  Kyle B Walsh; Kimberly Hart; Susan Roll; Matthew Sperling; Dusten Unruh; W Sean Davidson; Christopher J Lindsell; Opeolu Adeoye
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-03-16       Impact factor: 2.136

6.  The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.

Authors:  Mehryar Zargari; Fahimeh Sharafeddin; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

7.  Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients.

Authors:  Seema Sanjay Chawhan; Mukund R Mogarekar; Reena V Wagh; Rajkumar R Das; Sanjay S Pramanik; Sanjay M Sonune; Sanjay M Chawhan
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 8.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

9.  Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Yoshiko Sano; Kokoro Tsuzaki; Yukiyo Matsuoka; Kahori Egawa; Makiko Yoshimura; Chika Horikawa; Yoshinori Kitagawa; Yoshinobu Kiso; Satoshi Kimura; John Schulze; Jennifer Taing; Alejandro Gugliucci
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

10.  Association between paraoxonase gene and stroke in the Han Chinese population.

Authors:  Guojun Zhang; Wenjin Li; Zhiqiang Li; Hong Lv; Yonghong Ren; Ruimin Ma; Xiaohong Li; Xixiong Kang; Yongyong Shi; Yimin Sun
Journal:  BMC Med Genet       Date:  2013-01-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.